Motor and sensory impairment in survivors of childhood central nervous system ( CNS ) tumors in the St. Jude Lifetime Cohort ( SJLIFE )
Cancer Medicine · 2024-07 · 13 (14)
DOI: 10.1002/cam4.7422 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Medicine, online erschienen am 26.07.2024. Verfasst von Rozalyn L Rodwin und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Yale University School of Medicine, New Haven, Connecticut, USA. Hauptthemen laut MEDLINE: Central Nervous System Neoplasms, Cancer Survivors, Quality of Life. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: American Lebanese Syrian Associated Charities, Cancer Center Support Grant, NCI NIH HHS.
Abstract (Originalsprache)
Background
Survivors of childhood central nervous system (CNS) tumors can develop motor and sensory impairment from their cancer and treatment history. We estimated the prevalence of motor and sensory impairment in survivors compared with controls through clinical assessment and identified associated treatment exposures and functional, quality of life (QOL), and social outcomes.
Methods
Survivors of childhood CNS tumors from the St. Jude Lifetime Cohort ( n = 378, median [range] age 24.0 [18.0–53.0] years, 43.4% female) ≥5 years from diagnosis and controls ( n = 445, median [range] age 34.0 [18.0–70.0] years, 55.7% female) completed in‐person evaluation for motor and sensory impairment using the modified Total Neuropathy Score. Impairment was graded by modified Common Terminology Criteria for Adverse Events. Multivariable models estimated associations between grade ≥2 motor/sensory impairment, individual/treatment characteristics, and secondary outcomes (function by Physical Performance Test, fitness by physiologic cost index, QOL by Medical Outcomes Survey Short Form‐36 physical/mental summary scores, social attainment).
Results
Grade ≥2 motor or sensory impairment was more prevalent in survivors (24.1%, 95% Confidence Interval [CI] 19.8%–29.4%) than controls (2.9%, CI 1.4–4.5%). Among survivors, in multivariable models, motor impairment was associated with vinca exposure 2036 mg/m 2 versus none (OR 12.61, CI 2.19–72.72). Sensory impairment was associated with older age at diagnosis (OR 1.09, CI 1.01–1.16) and craniospinal irradiation versus none (OR 4.39, CI 1.68–11.50). There were lower odds of motor/sensory impairment in survivors treated in the year 2000 or later versus before 1990 (Motor: OR 0.29, CI 0.10–0.84, Sensory: OR 0.35, CI 0.13–0.96). Motor impairment was associated with impaired physical QOL (OR 2.64, CI 1.22–5.72).
Conclusions
In survivors of childhood CNS tumors, motor and sensory impairment is prevalent by clinical assessment, especially after exposure to etoposide, vinca, or craniospinal radiation. Treating motor impairment may improve survivors' QOL.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pediatrics, Yale University School of Medicine, New Haven, Connecticut, USA.
- Yale Cancer Center, New Haven, Connecticut, USA.
- Department of Epidemiology and Cancer Control, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
- Department of Biostatistics, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
- Department of Pediatrics, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
- Department of Psychology and Behavioral Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
ORCID-Profile: Rozalyn L Rodwin
Förderung
- American Lebanese Syrian Associated Charities
- Cancer Center Support Grant
- NCI NIH HHS
- NCATS NIH HHS
- COVID-19 Fund to Retain Clinical Scientists at Yale, sponsored by the Doris Duke Charitable Foundation award # 2021266, and the Yale Center for Clinical Invest…
- William O. Seery Mentored Research Award for Cancer Research, Bank of America, N.A., Trustee
- Hyundai Hope On Wheels
- National Cancer Institute
Zitieren
APA
Rodwin, R. L., Wang, F., Lu, L., Li, Z., Srivastava, D. K., Phillips, N. S., Khan, R. B., Brinkman, T. M., Krull, K. R., Boop, F. A., Armstrong, G. T., Merchant, T. E., Gajjar, A., Robison, L. L., Hudson, M. M., Kadan-Lottick, N. S., & Ness, K. K. (2024). Motor and sensory impairment in survivors of childhood central nervous system ( CNS ) tumors in the St. Jude Lifetime Cohort ( SJLIFE ). Cancer Medicine, 13(14). https://doi.org/10.1002/cam4.7422
Vancouver
Rodwin RL, Wang F, Lu L, Li Z, Srivastava DK, Phillips NS, et al. Motor and sensory impairment in survivors of childhood central nervous system ( CNS ) tumors in the St. Jude Lifetime Cohort ( SJLIFE ). Cancer Medicine. 2024;13(14). doi:10.1002/cam4.7422
BibTeX
@article{Rodwin2024,
author = {Rodwin, Rozalyn L and Wang, Fang and Lu, Lu and Li, Zhenghong and Srivastava, Deo Kumar and Phillips, Nicholas S and Khan, Raja B and Brinkman, Tara M and Krull, Kevin R and Boop, Frederick A and Armstrong, Gregory T and Merchant, Thomas E and Gajjar, Amar and Robison, Leslie L and Hudson, Melissa M and Kadan-Lottick, Nina S and Ness, Kirsten K},
title = {Motor and sensory impairment in survivors of childhood central nervous system ( CNS ) tumors in the St. Jude Lifetime Cohort ( SJLIFE )},
journal = {Cancer Medicine},
year = {2024},
volume = {13},
number = {14},
doi = {10.1002/cam4.7422}
}
EUVIMED